Get started

Shortsqueeze

AMC Pattern Update for the week and maybe even nextQuick little update for this week. Wednesday morning should be good. In the case we don't go back down to the downside. We should see a re-test of 46.88 and a bounce to the upside off that. In the case we do go below the resistance (46.88) to the downside, The bottom to that trend should be in the range of 46.08 to 45.31. IF we drop below resistance, what I believe we could see happening is a lot of volatility and consolidation for the week and into the next week as-well. Side Note: Im still very bullish for the week and even next week but once we hit price targets referenced in my first AMC post linked below. We will see red days in a reteracement towards previous resistances which will be posted here once we get there. We are doing absolutely amazing everyone. Happy trading and remember, don't sell w/ the Hedge funds!!! Edit: The green dotted line is the resistance at 46.88. Referenced because that's the re-test line mentioned above.
NYSE:AMCLong
by GreenDayTrade
$ROOTRetail investing subreddit r/WallStreetBets has spun the short-squeeze-stock wheel this morning and it appears the arrow is landing on ROOT. The company is exploding on the subreddit in terms of comments, and the stock is moving in massive quantities. Some are making their exit as ROOT stock sees a boom and bust this morning, whereas others are buying in and predicting a squeeze that will boost their long positions. If you don’t know already ROOT is a car insurance company with an innovative model. It insures only good drivers. Users must download a location-tracking app to leave on when they drive during a test period. Users deemed by the app to be a good driver are offered a competitive insurance premium through the company. The result is that the company only insures drivers who are typically much safer. This allows ROOT to offer lower premiums than other insurers who must account for more dangerous clients. ROOT stock is one of the more heavily shorted by Wall Street institutions; about 19.5% of ROOT’s float is being sold short. The r/WallStreetBets crowd has been recently pouring into the stock as a result. When we look at the technical side of things ROOT seems to be sitting in a huge falling wedge on the daily chart since going public. This could give a good opportunity if we break above resistance. I suggest keep things on your watchlist as we come towards the end of the falling wedge. Watchlist activated! - Factor Four
NASDAQ:ROOTLong
by TheBlankFund
2
AMC Start of a New Run?30 Minute Chart As you can see, previously we dipped down 17% from $39 to $32. Then we went from $32 all the way to our current highs of $48 around a 50% gain. We have now seen a drop of around 17% from $48 to $40. MACD is also showing signs of crossover to upside. RSI showing a similar trend which we have hit the 30 level on RSI. In both RSI patterns we have seen a bounce back to the overbought region (+70 RSI). if we continue this pattern we could see another similar run up around 50% which would make for a 20 pt move from $40 to $60. Please let me know what you guys think ! All comments welcome. Leave a like if you enjoyed this setup.
NYSE:AMCLong
by Smarter_Trades
5
KALA Levels + Short InfoShort squeeze stocks have become a favorite recently. KALA has started getting wrapped into the conversation. Looking at details from sites like FinViz, short float is around 20% meanwhile the float itself shows to be around 42 million shares. Plotting some levels, you'll notice that KALA is still in the lower channel on the fib retracement slowly heading toward the 786 area. However, before that happens, keep watch on an interim level around $3.40. It was previously a support level in July but seems to have become a resistance level as KALA was strongly rejected right at $3.40 on Friday. Aside from the technical/speculative trend, there are also a few things to watch with the company after a rough first half: " Kala specializes in eye treatments. Its EYSUVIS is quickly playing a leading role for the company. According to the company, this past quarter, it was a preferred prescription for short-term treatment of dry eye disease. Furthermore, Kala explained that its expanding market access with Commercial and Medicare Part D health plans...Mark Iwicki, Chairman, President, and Chief Executive Officer of Kala Pharmaceuticals, explained, “We are encouraged by the very positive feedback we consistently receive from physicians and patients, who describe EYSUVIS as an effective and comfortable medicine and look forward to building on this foundation as we continue with the EYSUVIS launch. In parallel, we continue to promote INVELTYS and are advancing our pipeline of new chemical entities for front and back of the eye diseases, as we work to build a robust and sustainable portfolio of innovative treatments.” " Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
NASDAQ:KALA
by PennyStocks101
CLVS back on the low lowCLVS is now back at its November 2020 low. The interesting part of this trend is that it also managed to test, hold, and bounce off of an almost identical level (strong support?). As of Friday afternoon shares retested an interim area of higher traffic that was support earlier in August and late July but now appears to have become a resistance level over the last 3 sessions at least. With the "short squeeze stocks" conversation building steam, it could be interesting for CLVS. Finviz shows the short float percentage at 27% right now. " The biotech sector may also host some of the other heavily shorted stocks. Phase trial data, scientific reports, and the like all play a role in directional momentum. In this case, Clovis has felt some pressure over the last few quarters. Clinical data on its FAP-2286 platform, along with missed earings, haven’t helped the cause. Then you’ve got news of large, multi-million dollar fundraising initiatives adding more pressure as well. Needless to say, it has happened to hopefully advance the company’s pipeline...Clovis specializes in developing cancer treatments. Its lead candidate Rubraca is an oral treatment being developed in multiple types of tumors. These include ovarian and prostate cancers. It’s approved in the US for maintenance treatment in adults with recurrent epithelial, ovarian, fallopian tube, or primary peritoneal cancers...As far as CLVS being considered one of the “short squeeze stocks,” outlets show that the penny stock’s short-interest sits around 27%. Of course, it isn’t as high as some of the others on this list. However, anything over 20%, by most accounts, can be considered high. " Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
C
by PennyStocks101
ATER Trying To Redeem ItselfWe've looked at countless charts and share structures of the so called "short squeeze stocks" with ATER popping up. While it isn't the highest short interest, sites like finviz point out a short float percentage of over 20%. Further, the penny stock fell hard in August after filing a registration statement for selling shareholders at 2.7 million shares. Thanks to the likes of SPRT BBIG and even MMAT , these high-short interest stocks are the talk of the market right now. The big question is will they hold up to the hype and how long will the moves last IF they even begin in the first place? " While no news was announced sparking this gain, we did see many tech penny stocks climb during today’s session. However, it did report its second quarter 2021 financial results only a few weeks ago. In the results, the company reported 14% growth in its revenue YoY to $68.2 million. In addition, it managed to grow its gross margin from 46.7% to 48% in addition to decreasing its operating expenses from $29.4 million to $28.4 million...“This has been a challenging quarter for e-commerce marked by a global supply chain crisis, inflation and an extreme shift in consumer behavior due to the opening of brick and mortar stores after the relaxation of COVID-19 related restrictions...Despite the difficult environment and significant increase in product variable cost, our sales grew on average 20% on a proforma basis across all fourteen brands compared to the second quarter of 2019.” The Co-Founder and CEO of Aterian Inc., Yaniv Sarig " Quote Source & Read More: These 3 Penny Stocks Exploded on Friday, Here’s Why
NASDAQ:ATER
by PennyStocks101
Will These Levels MMAT er This Week?MMAT has been on the list of short squeeze stocks recently. SPRT 's big move along with BBIG 's big pop helped spotlight some stocks with higher short interest. For this retracement, we didn't do much more than extend out the same fib retracement we plotted in July, which still appears to show relevancy. What's more, is MMAT has a few other things to keep in mind outside of the typical technical/speculative trends: " The company recorded 197% revenue growth in the second quarter as it continues seeking new contracts. This comes as Meta Materials works to button up yet another acquisition. This one is for Nanotech Security Corp., valued at just under C$91 million. The deal is expected to expand and speed up Meta’s commercialization strategy. In particular, it brings Nanotech’s electron beam lithography equipment anticipated to decrease production costs noticeably. “Nanotech also adds complementary skillsets which can support META’s markets, accelerating our commercialization plans in verticals such as solar energy, 5G and other antennas, battery and fuel cells, and carbon capture,” said George Palikaras, META’s President and CEO...As it relates to MMAT stock short interest, outlets are showing a short float as of today’s date above 40%. However, it does make sense that some have taken bearish bets on the company considering all of the cash laid out for its current and pending acquisitions. Needless to say, it has been one of the penny stocks to watch this week. " Quote Source & Read More: 4 Short Squeeze Penny Stocks To Watch After SPRT Stock’s 1,309% Run
M
by PennyStocks101
AMC Short Squeeze Prediction (Third Times A Charm)When looking at AMC's price action in the previous months, September, particularly the week of 6th-10th, is looking real bullish for AMC. The first squeeze attempt happened Wednesday January 27th, the second Wednesday June 2nd. Both occurred in weeks where Monday landed on a holiday. Is it a coincidence that AMC's price action is rising and that September 6th happens to also be a holiday? Take this with a grain of salt because AMC is a hard one to predict, but September 8th looks really good on my calendar.
NYSE:AMCLong
by TradingWithEmotion
3
$Aso, High probability short squeeze by swing tradingThe stock is holding at the area of 42.69. it's no right time for an entry, as the stock is extended from it's 5 & 10 period moving average where we expect the price to consolidate or pull back producing a right entry at the are of 42.69, the stock is highly correlated with the General market and should be traded with high caution. stock can be traded in daily, hourly or any other intraday time frame as per your style of trading. if anything, please do drop a comment below. thank you. Real time trade with educational purpose, please don't forget to do your homework.
NASDAQ:ASOLong
by localogist